Showing results (11-20 of 374) with videos related to
Sort By:
Pageof 38
JAMA Network Open|March 15, 2022
Cancer Drug Approvals That Displaced Existing Standard-of-Care Therapies, 2016-2021David J Benjamin, Alexander Xu, Mark P Lythgoe, et al.Familial Cancer|December 1, 2017
Metachronous colorectal cancer following segmental or extended colectomy in Lynch syndrome: a systematic review and meta-analysisSalim S Malik, Mark P Lythgoe, Mark McPhail, et al.Trends in Cancer|May 9, 2024
Lifileucel: the first cellular therapy approved for solid tumoursMax Julve, Mark P Lythgoe, James Larkin, et al.Trends in Microbiology|September 4, 2022
Polymorphic microbes: a new emerging hallmark of cancerMark P Lythgoe, Benjamin H Mullish, Adam E Frampton, et al.Journal of Clinical Pathology|October 19, 2023
Gene of the month: cancer testis antigen gene 1b (NY-ESO-1)Max Julve, Oliver Kennedy, Adam Enver Frampton, et al.Molecular Oncology|April 28, 2009
Has the US Cancer Centre model been 'successful'? Lessons for the European cancer communityRichard SullivanEcancermedicalscience|March 1, 2024
Cancer medicines: a private vice for public benefit?Richard SullivanMolecular Oncology|April 23, 2009
Cancer research in the UK: A policy review of the junior academic clinical facultyRichard SullivanTrends in Microbiology|October 29, 2021
The potential of fecal microbiota transplantation in oncologyMark P Lythgoe, Rohma Ghani, Benjamin H Mullish, et al.Trends in Cancer|April 7, 2024
The evolving posology and administration of immune checkpoint inhibitors: subcutaneous formulationsMatthew J Hadfield, David J Benjamin, Jonathan Krell, et al.Pageof 38